Sergey Edunov serves as the Chief Technology Officer (CTO) at Genesis Molecular AI, where he applies artificial intelligence to the complex domain of drug discovery. His work at Genesis Molecular AI aims to leverage AI for significant opportunities and value in the world.
Prior to his current role, Edunov was a Director of Engineering at Meta. In this capacity, he led teams of research scientists and engineers responsible for key company initiatives.